These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33131542)

  • 1. Renal and Hepatic Health After Childhood Cancer.
    Ehrhardt MJ; Skinner R; Castellino SM
    Pediatr Clin North Am; 2020 Dec; 67(6):1203-1217. PubMed ID: 33131542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
    Mulder RL; Bresters D; Van den Hof M; Koot BG; Castellino SM; Loke YKK; Post PN; Postma A; Szőnyi LP; Levitt GA; Bardi E; Skinner R; van Dalen EC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD008205. PubMed ID: 30985922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group.
    Bardi E; Mulder RL; van Dalen EC; Bhatt NS; Ruble KA; Burgis J; Castellino SM; Constine LS; den Hoed CM; Green DM; Koot BGP; Levitt G; Szonyi L; Wallace WH; Skinner R; Hudson MM; Kremer LCM; Effinger KE; Bresters D
    Cancer Treat Rev; 2021 Nov; 100():102296. PubMed ID: 34571378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine Sequelae in Childhood Cancer Survivors.
    George SA; Effinger KE; Meacham LR
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):565-587. PubMed ID: 33153668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'Survivorship Passport' for childhood cancer survivors.
    Haupt R; Essiaf S; Dellacasa C; Ronckers CM; Caruso S; Sugden E; Zadravec Zaletel L; Muraca M; Morsellino V; Kienesberger A; Blondeel A; Saraceno D; Ortali M; Kremer LCM; Skinner R; Roganovic J; Bagnasco F; Levitt GA; De Rosa M; Schrappe M; Hjorth L; Ladenstein R; ;
    Eur J Cancer; 2018 Oct; 102():69-81. PubMed ID: 30138773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.
    Castellino S; Muir A; Shah A; Shope S; McMullen K; Ruble K; Barber A; Davidoff A; Hudson MM
    Pediatr Blood Cancer; 2010 May; 54(5):663-9. PubMed ID: 19890896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.
    Mulder RL; Kremer LC; Koot BG; Benninga MA; Knijnenburg SL; van der Pal HJ; Koning CC; Oldenburger F; Wilde JC; Taminiau JA; Caron HN; van Dalen EC
    Eur J Cancer; 2013 Jan; 49(1):185-93. PubMed ID: 22901831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.
    Skinner R
    Pediatr Nephrol; 2018 Feb; 33(2):215-225. PubMed ID: 28434047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing and Other Neurologic Problems.
    Landier W; Cohn RJ; van den Heuvel-Eibrink MM
    Pediatr Clin North Am; 2020 Dec; 67(6):1219-1235. PubMed ID: 33131543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
    van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
    Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine Health in Childhood Cancer Survivors.
    van Santen HM; Chemaitilly W; Meacham LR; Tonorezos ES; Mostoufi-Moab S
    Pediatr Clin North Am; 2020 Dec; 67(6):1171-1186. PubMed ID: 33131540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.
    Jones DP; Spunt SL; Green D; Springate JE;
    Pediatr Blood Cancer; 2008 Dec; 51(6):724-31. PubMed ID: 18677764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diseases of renal function and bone metabolism after treatment for early onset cancer: A registry-based study.
    Liuhto N; Grönroos MH; Malila N; Madanat-Harjuoja L; Matomäki J; Lähteenmäki P
    Int J Cancer; 2020 Mar; 146(5):1324-1332. PubMed ID: 31523804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal late effects in patients treated for cancer in childhood].
    Sudour-Bonnange H; Vanrenterghem A; Nobili F; Guigonis V; Boudailliez B
    Bull Cancer; 2015; 102(7-8):627-35. PubMed ID: 25935232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer.
    Visscher H; Otth M; Feijen EAML; Nathan PC; Kuehni CE
    Pediatr Clin North Am; 2020 Dec; 67(6):1155-1170. PubMed ID: 33131539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive Complications in Childhood Cancer Survivors.
    van Santen HM; van de Wetering MD; Bos AME; Vd Heuvel-Eibrink MM; van der Pal HJ; Wallace WH
    Pediatr Clin North Am; 2020 Dec; 67(6):1187-1202. PubMed ID: 33131541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Genetic Risk Contributing to Long-Term Adverse Treatment Effects in Childhood Cancer Survivors.
    Gramatges MM; Bhatia S
    Annu Rev Med; 2018 Jan; 69():247-262. PubMed ID: 29029584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for premature aging in childhood cancer survivors.
    Krawczuk-Rybak M; Latoch E
    Dev Period Med; 2019; 23(2):97-103. PubMed ID: 31280245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.